CardioComm Solutions, Inc. announced that it has completed a HeartCheck(TM) and SMART Monitoring distribution and co-marketing agreement with Reka Health, Inc. REKA will promote sales of the HeartCheck(TM) PEN through their own, proprietary international distribution channels, including US-based accountable care organization (ACO) patient portals. The Agreement confirms CardioComm Solutions will integrate the REKA E100, a Smartphone connected, handheld, single lead, 30 second ECG cardiac event monitor with CardioComm Solutions' patent-pending SMART Monitoring ECG service to support physician prescribed use of the REKA E100. In return, REKA will co-promote the HeartCheck(TM) PEN ECG as their over-the-counter (OTC) solution for ECG self-monitoring.

Both companies will share in the SMART Monitoring service revenue where REKA has managed the sale of either the HeartCheck(TM) PEN or the REKA E100. Additionally, CardioComm Solutions plans to expand their HeartCheck(TM) OTC 510K clearance from the Food and Drug Administration (FDA) to include the REKA E100. CardioComm Solutions will benefit with a share of the revenue from the sale of each REKA device and REKA will benefit from ECG reading service revenue derived through the SMART Monitoring ECG service.

The Companies will pair their respective technologies where the REKA Smartphone application and HIPPA compliant cloud-based platform (REKA Cloud) will direct all HeartCheck(TM) enabled REKA E100 devices to transmit recorded ECGs into the CardioComm Solutions SMART Monitoring environment. The REKA Smartphone App is compatible with AndroidTM OS and iOS(R) Smartphones. From there, customers will be able to receive ECG reports through the CardioComm Solutions GEMS Home and/or through the REKA Cloud.

CardioComm Solutions holds a unique market distinction of having independent Class II medical device FDA clearances on their ECG viewing and reporting software technology used within the SMART Monitoring ECG service. Such clearances to view and report ECGs, regardless of the device used to record and transmit the ECG file, is important in enabling physicians to confidently render reliable ECG interpretations. Such clearances will strengthen both Companyies efforts to access markets such as the veterans' administration-based ACO patient portals, which are now interested in providing both prescribed and OTC access to ECG monitoring services to their patients.